Background Because pulmonary artery size is considered by most investigators to be a major prognosticator of outcome in patients undergoing staged Fontan reconstruction, the objective of the present study was to determine the efficacy of noninvasive measures in determining pulmonary artery size.
Methods and Results
This study analyzed the Ti-weighted, spin-echo magnetic resonance and echocardiographic images of 36 functional single-ventricle patients throughout stages of Fontan reconstruction (prebidirectional and postbidirectional cavopulmonary anastomosis and after Fontan) and compared them with angiography images at cardiac catheterization. Magnetic resonance imaging had a high degree of agreement with angiography, with the McGoon index agreeing better than the Nakata index and absolute right and left pulmonary diameters. Although echocardiography had fair agreement with angiography, it agreed less well and had a wider standard deviation than magnetic resonance imaging for all indexes and measurements and, based on the prediction interval, would be a poorer prospective measure of pulmonary artery size in this population. In addition, echocardiography was a poorer measure of pulmonary artery size as the size of the vessel Since 1971, when Fontan pioneered reconstructive surgery for patients with single-ventricle physiology,1 numerous investigators have sought predictors of successful outcome2-9 through subsequent modifications and application to various congenital heart defects.10-'4 Pulmonary artery size, although controversial, appears to be a prognostic indicator.4-8 It may also be used by the surgeon as preoperative information and may ultimately affect the conduct of the surgery if the pulmonary arteries need to be augmented.
The noninvasive assessment of pulmonary artery size would therefore be useful and has been attempted in the past with two-dimensional echocardiography.215"16 A rigorous study comparing this modality and magnetic resonance imaging with angiography, however, has not increases. Magnetic resonance imaging correctly detected five of five patients with nonconfluent branch pulmonary arteries and six of six patients with stenoses, whereas echocardiography was unable to visualize any of the patients with nonconfluent branch pulmonary arteries with certainty and only two of six (33%) with stenoses.
Conclusions Magnetic resonance imaging is a useful, noninvasive toot to determine pulmonary artery size in patients undergoing Fontan reconstruction and is superior to echocardiography. Echocardiography was a fair predictor of pulmonary artery size, but magnetic resonance imaging agreed with angiography better than echocardiography and outperformed echocardiography in diagnosing branch 20, 1990 . The exclusion criteria for the study was not being stable enough to undergo a 1-hour magnetic resonance scan under sedation, the The anatomic features of the 36 study patients are summarized in Table 1 . Twenty-three (64%) had hypoplastic left heart syndrome, 5 (14%) had double-outlet right ventricle (with an atrioventricular valve either markedly hypoplastic or atretic and pulmonic stenosis), 3 (8%) had tricuspid atresia, 2 (6%) had pulmonary atresia with intact ventricular septum, 1 (3%) had isolated ventricular inversion with left atrioventricular valve atresia, 1 (3%) had single left ventricle with right ventricular outlet chamber and pulmonary atresia, and 1 (3%) had transposition of the great arteries with mitral and pulmonary hypoplasia. The breakdown by surgical subgroup consisted of 16 (44%) prior to having bilateral cavopulmonary anastomosis (ie, hemi-Fontan procedure -superior vena cavato-pulmonary artery anastomosis with right atrial exclusion), 11 (31%) who had undergone a hemi-Fontan procedure but had not undergone Fontan completion (baffling inferior vena caval blood flow to the pulmonary artery), and 9 (25%) who had completed the modified Fontan reconstruction. Table 2 gives study patients by surgical subgroup tabulating age, body surface area, height, and weight. (Fig 1) . Injections were made either directly into the pulmonary arteries or into vessels just proximal to pulmonary artery flow (ie, ascending neoaorta in patients who are status post-stage I Norwood reconstruction, antecubital or subclavian vein in patients who are status post-hemi-Fontan, and so on). Cineangiograms were recorded on standard 35-mm film, and measurements were made using a Vangard XR-35 viewing system (Vangard Instrument Corp), using catheter diameter as an internal standard. Measurements of pulmonary artery size were taken along the most uniform part of the vessel just proximal to the first lobar branch. Discontinuities and stenoses were identified and recorded. The resolution is 0.7 mm (2.7 line pairs per millimeter). Because the diameter of the great vessels changes during the cardiac cycle, the dimensions at end systole and end diastole were averaged to obtain the angiographic value.
Echocardiography
Before imaging, all patients less than 3 years old were sedated with 75 to 120 mg/kg chloral hydrate PO. If more than 3 years old, depending on the ability to cooperate with the examination, the patient either was or was not sedated with chloral hydrate as described. Echocardiograms were performed within 2 weeks before cardiac catheterization. A comprehensive two-dimensional echocardiographic examination was performed on each patient, and measurements were made from leading edge to leading edge using electronic calipers from the suprasternal notch frontal position in the case of the right pulmonary artery, the suprasternal notch left anterior oblique view angling to the left in the case of the left pulmonary artery, or the high parasternal positions (Fig 2) . Measurements of pulmonary artery size were taken along the most uniform part of the vessel just proximal to the first lobar branch. Hewlett Packard 77020 phased-array ultrasound systems (Sonos 500 and 1000) with 5.0-, 3.5-, or 2.5-MHz transducers were used. All studies were recorded on ½/2-in VHS format videotapes and were available for retrospective off-line analysis. Because the suprasternal notch views were used, measurement of pulmonary artery size was a function of the axial resolution of the two-dimensional image. The axial resolutions for the 5-, 3.5-, and 2.5-MHz transducers were 0.7, 0.9, and 1.1 mm, respectively. Because the diameter of the great vessels changes during the cardiac cycle, the dimensions in end systole and end diastole were averaged to obtain the echocardiographic value. Color flow mapping was not used in the calculations of pulmonary artery size because of its poor spatial resolution (decreased line density would preclude accurate size measurements30,3t; however, it was used in the determination of branch pulmonary artery discontinuity.
Magnetic Resonance Imaging
All patients were sedated before imaging. If less than 2 years old, the patient was given either 75 to 120 mg/kg chloral hydrate PO or 2 to 6 mg/kg nembutal IV. If more than 2 years old, either 4 mg/kg nembutal PO and 3 mg/kg demerol PO or 2 to 6 mg/kg nembutal IV was administered. All patients were monitored with pulse oxymetry, nasal end-tidal CO2 monitoring, ECG, and direct visualization via closed-circuit television. All patients tolerated sedation without incident.
All studies were performed on a Siemens 1.5-T Magnetom. The scanning protocol consisted of a coronal localizer (to locate the heart in the chest) followed by two sets of interleaved, Ti-weighted transverse images (Fig 3) 3 Images containing the branch pulmonary arteries were identified, and measurements were made from leading edge to leading edge (Fig 3) . Measurements of pulmonary artery size were taken along the most uniform part of the vessel just proximal to the first lobar branch. Data were then converted from pixel length to millimeters by a factor determined by the field of view and matrix size. The resolution was 1 mm.
Because magnetic resonance imaging obtains contiguous, parallel slices, the diagnosis of pulmonary artery discontinuity was aided by off-line analysis on our Sun workstation (Sun Microsystems) using an oblique sectioning program from a multidimensional, user-interactive software package called VIDA,32 which was developed in our laboratory. This allowed for computer reconstruction of sagittal and coronal images from the transverse ones (Fig 4) . Discontinuity was defined as nonconfluency of the pulmonary arteries in all three orthogonal planes.
Calculations
Although raw numbers were used when comparing the various imaging modalities, two indexes of pulmonary size that are in the literature were also calculated and used in the data analysis. The Nakata index4 uses the cross-sectional area of both branch pulmonary arteries (right [RPA] t statistic with 2.5% of the area under the t distribution and n-1 df SD is the standard deviation, and n is the number of observations. If this interval contains 0, there is 95% confidence that no significant bias is present, and if it does not contain 0, then there is 95% confidence that a significant bias exists. A "prediction interval" is then constructed, which predicts where 95% of the population as a whole will fall given our data, using the following formula:
Prediction Interval = Mean Difference ± 2 x SD Finally, a plot of the difference between the imaging modality and angiography versus angiography is constructed to determine how the difference varies with the size of the pulmonary artery.
Comparison of magnetic resonance imaging and echocardiographic differences with angiography was made using the paired, two-tailed Student's t test. Comparison between right and left pulmonary arteries across surgical subgroups used two-factor ANOVA with repeated measures. Pairwise comparison between different groups used two-factor ANOVA modified by the Bonferroni correction.
Both intraobserver and interobserver variability were made by the coefficient of variability, defined as Coefficient of Variability= Observation 1-Observation 2 Mean of Observation 1 + Observation 2 and then computing the mean±SD for each structure and imaging modality (Table 3) . Interobserver variability was measured between two independent observers who were blinded to the other's results. Table 4 displays the raw data from angiocardiography, the gold standard used in this study, as well as pulmonary artery size determined by magnetic resonance imaging and echocardiography. The mean values for right and left pulmonary arteries showed little difference between mean values from magnetic resonance imaging and angiography in each of the three indexes or measurements: the McGoon index (0.01 for each), Nakata index (9 mm2/m2 body surface area), and absolute branch pulmonary artery size (0.21 and 0.03 mm, respectively). Echocardiographic difference between mean values was much greater than that for magnetic resonance imaging (McGoon index, by 10 times for the right pulmonary artery and 7 times for the left pulmonary artery; Nakata index, by slightly more than 3 times and, in absolute measures, by 3 times for the right pulmonary artery and 20 times for the left pulmonary artery) (P<.05). The mean value of the pairwise differences between magnetic resonance imaging and angiography (ie, mean difference in Table 4 : mean value for all patients of the branch pulmonary artery size by magnetic resonance imaging minus the value as determined by angiography) was smaller than echocardiography for the McGoon and Nakata indexes but not for absolute size. Note, however, that the standard deviation of the pairwise differences is much greater for echocardiography than for magnetic resonance imaging (P<.05). 
Results

Branch Pulmonary Artery Measurements
Pulmonary Artery Discontinuity and Stenoses
Magnetic resonance imaging correctly detected five of five patients with branch pulmonary artery discontinuity (Fig 4) and six of six with stenoses. Echocardiography, using two-dimensional imaging and color flow mapping, was unable to detect any nonconfluent branch pulmonary arteries with certainty and only two of six (33%) 
Discussion
When Choussat and Fontan published their selection criteria for the Fontan procedure in 1978,5 they listed in their "Ten Commandments" that the pulmonary artery-to-aortic diameter ratio be 20.75. Since then, there has been much discussion in the literature concerning the usefulness of pulmonary artery size both as a preoperative requirement and as a predictor of outcome. [2] [3] [4] [5] [6] [7] There are a number of studies that support the notion that pulmonary artery size plays an important role. Nakata et a14 in 1984 initially published their index to gauge the size of the pulmonary artery and found it useful in predicting postoperative prognosis. In a review of 167 Fontan cases, Mayer et a17 in 1986 found 109 (67%) exceeded one or more of the original selection criteria, and multivariate analysis showed that pulmonary artery distortion "had a significant negative impact" on survival. Norwood et a18 suggested that left pulmonary artery hypoplasia may be a cause of death in some patients with hypoplastic left heart syndrome undergoing the Fontan procedure. Fontan et a16 published a multicenter series of 334 patients in 1989 and concluded that "one of the most powerful risk factors a.
- and ultimate conduct of the surgery. They concluded that "patients should not be excluded from consideration for Fontan's repair solely on the basis of pulmonary artery size." Given the usefulness of pulmonary artery size in this group of patients, noninvasive assessment of pulmonary artery size would be a useful number to factor into the Fontan patient's equation. We therefore elected to study whether echocardiography and magnetic resonance imaging would give the same information as angiography.
Our results showing that echocardiography did not reflect the pulmonary artery size determined by angiography as well as magnetic resonance imaging may be in part due to the oblique angle with which the vessel is cut on echocardiography. A true coronal image, which is seen on the anteroposterior angiogram, is not readily obtained by echocardiography from the suprasternal notch position. Furthermore, right pulmonary artery size was better assessed by echocardiography than left pulmonary artery size, whether using the absolute measures or the McGoon index. This may be due to the posterior course the left pulmonary artery takes and its poor visualization in that position of the thorax. It is also interesting to note that as the size of the pulmonary artery increases (eg, as patients progress through the stages of Fontan reconstruction and as they age), the agreement between angiocardiography and echocardiography of pulmonary artery size became poorer. This may be explained by the fact that those patients with larger pulmonary arteries are generally older and bigger, which in turn increases the technical difficulty of the echocardiographic study, whereas magnetic resonance imaging does not have this handicap.
Magnetic resonance imaging was found to be superior to echocardiography in measuring pulmonary artery size for all indexes in all statistical descriptions. This was found to be the case when comparing mean values (Table 4) , prediction interval ( 
Study Limitations
Only suprasternal notch imaging or high parasternal imaging was used in transthoracic echocardiography for the calculation of pulmonary artery size because of the consistently high-quality imaging of those structures in nearly all patients. It is possible that subcostal imaging or transesophageal echocardiography offers a better delineation of pulmonary artery size.
Conclusions
Magnetic resonance imaging is a useful, noninvasive tool to determine pulmonary artery size, stenosis, and branch pulmonary artery discontinuity in patients undergoing Fontan reconstruction. Although echocardiography was a fair predictor of pulmonary artery size, magnetic resonance imaging is superior to echocardiography for measurement 
